Botanic Healthcare launches Rs. 25 crore liposomal manufacturing facility in Hyderabad
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval
Accro will retain global rights to develop, manufacture, and commercialize AC-201 (excluding Chinese Mainland, Hong Kong SAR, and Macau SAR)
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
This strategic investment strengthens Cohance's integrated oligonucleotide platform
This will be Aster’s fifth hospital in Bengaluru
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Subscribe To Our Newsletter & Stay Updated